| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXJ2 HIVEP1 HIVEP2 RARB ZNF628 GLIS3 HIC2 ZKSCAN7 NKX2-6 ZNF395 GATA5 BCL11A FOXA1 PRDM1 TBX19 SALL2 SMARCA4 ZFHX2 FOXO4 NKX6-1 MUC1 TP73 FOXI1 | 8.89e-07 | 1244 | 118 | 23 | GO:0000978 |
| GeneOntologyMolecularFunction | transcription coregulator activity | NACA BCORL1 BCL11A ZFPM1 MED13L MED15 CIITA SETD5 TOX3 SMARCA2 SMARCA4 SMARCC1 SPEN MUC1 MED13 | 1.15e-06 | 562 | 118 | 15 | GO:0003712 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXJ2 HIVEP1 HIVEP2 RARB ZNF628 GLIS3 HIC2 ZKSCAN7 NKX2-6 ZNF395 GATA5 BCL11A FOXA1 PRDM1 TBX19 SALL2 SMARCA4 ZFHX2 FOXO4 NKX6-1 MUC1 TP73 FOXI1 | 1.29e-06 | 1271 | 118 | 23 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXJ2 HIVEP1 HIVEP2 RARB ZNF628 GLIS3 HIC2 ZKSCAN7 NKX2-6 ZNF395 GATA5 BCL11A FOXA1 PRDM1 TBX19 SALL2 ZBTB40 ZFHX2 FOXO4 NKX6-1 MYRF TP73 FOXI1 | 7.49e-06 | 1412 | 118 | 23 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXJ2 HIVEP1 HIVEP2 RARB ZNF628 GLIS3 HIC2 ZKSCAN7 NKX2-6 ZNF395 GATA5 BCL11A FOXA1 PRDM1 TBX19 SALL2 SMARCA4 ZFHX2 FOXO4 NKX6-1 MUC1 TP73 FOXI1 | 1.27e-05 | 1459 | 118 | 23 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | FOXJ2 HIVEP2 ZNF628 GLIS3 NKX2-6 ZNF395 FOXA1 TBX19 SALL2 FOXO4 TP73 FOXI1 | 1.21e-04 | 560 | 118 | 12 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | FOXJ2 HIVEP2 ZNF628 GLIS3 NKX2-6 ZNF395 FOXA1 TBX19 SALL2 FOXO4 TP73 FOXI1 | 1.33e-04 | 566 | 118 | 12 | GO:0001216 |
| GeneOntologyMolecularFunction | DNA polymerase binding | 3.27e-04 | 23 | 118 | 3 | GO:0070182 | |
| GeneOntologyMolecularFunction | chromatin binding | PCGF2 TSPY26P FOXA1 PRDM1 TNRC18 SF3B1 TOX3 SMARCA2 SMARCA4 SMARCC1 FOXO4 CHD6 NKX6-1 | 4.29e-04 | 739 | 118 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SHANK1 NACA BCORL1 BCL11A ZFPM1 MED13L MED15 CIITA SETD5 TOX3 SMARCA2 SMARCA4 SMARCC1 SPEN MUC1 CAPRIN1 MED13 | 4.66e-04 | 1160 | 118 | 17 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription factor binding | RARB NACA BCL11A ZFPM1 FOXA1 CIITA ARID2 SMARCA4 FOXO4 CHD6 SPEN MED13 TP73 | 5.12e-04 | 753 | 118 | 13 | GO:0008134 |
| GeneOntologyMolecularFunction | molecular adaptor activity | SHANK1 NACA BCORL1 BCL11A ZFPM1 MED13L HCN2 MED15 CIITA SETD5 TOX3 SMARCA2 SMARCA4 SMARCC1 SPEN MUC1 CAPRIN1 MED13 | 9.99e-04 | 1356 | 118 | 18 | GO:0060090 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.35e-03 | 37 | 118 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.17e-03 | 303 | 118 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.39e-03 | 582 | 118 | 10 | GO:0140297 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 2.42e-03 | 229 | 118 | 6 | GO:0003714 | |
| GeneOntologyMolecularFunction | helicase activity | 2.48e-03 | 158 | 118 | 5 | GO:0004386 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXJ2 HIVEP1 HIVEP2 RARB NACA GLIS3 NKX2-6 ZNF395 GATA5 ZFPM1 SPAG8 FOXA1 MED15 TBX19 SALL2 SF3B1 CIITA ARID2 TOX3 MEPCE SMARCA2 SMARCA4 SMARCC1 FOXO4 CHD6 NKX6-1 MUC1 MED13 TP73 FOXI1 | 1.23e-10 | 1390 | 117 | 30 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | PCGF2 HIVEP1 RARB NACA BCORL1 GLIS3 HIC2 GATA5 BCL11A ZFPM1 FOXA1 PRDM1 ZNF469 SALL2 CIITA MEPCE SMARCA2 SMARCA4 NKX6-1 SPEN | 1.83e-06 | 1053 | 117 | 20 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | PCGF2 HIVEP1 RARB NACA BCORL1 GLIS3 HIC2 GATA5 BCL11A ZFPM1 FOXA1 PRDM1 ZNF469 SALL2 CIITA SETD5 NFKBIE MEPCE SMARCA2 SMARCA4 NKX6-1 SPEN MUC1 | 3.24e-06 | 1399 | 117 | 23 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | PCGF2 HIVEP1 RARB NACA BCORL1 GLIS3 HIC2 GATA5 BCL11A ZFPM1 FOXA1 PRDM1 ZNF469 SALL2 CIITA SETD5 NFKBIE MEPCE SMARCA2 SMARCA4 NKX6-1 SPEN MUC1 | 3.83e-06 | 1413 | 117 | 23 | GO:1902679 |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 3.88e-06 | 42 | 117 | 5 | GO:0070316 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 4.90e-06 | 44 | 117 | 5 | GO:0045023 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | EVL CDSN PCGF2 RARB NACA GATA5 ZFPM1 C12orf57 FOXA1 SHROOM2 PRDM1 STIM1 ADM TBX19 ARID2 SMARCA4 SMARCC1 TNFAIP3 NKX6-1 SDK1 FOXI1 | 8.43e-06 | 1269 | 117 | 21 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 2.09e-05 | 29 | 117 | 4 | GO:2000819 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SHANK1 EVL NUMBL BRSK2 BCL11A ZFPM1 PAK6 C12orf57 SHROOM2 DIP2A MAP1S FARP1 SMARCA4 NKX6-1 ROBO3 BRSK1 CAPRIN1 ZMYM3 ARHGAP33 | 4.11e-05 | 1194 | 117 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SHANK1 EVL NUMBL BRSK2 BCL11A PAK6 C12orf57 DIP2A MAP1S FARP1 NKX6-1 ROBO3 BRSK1 CAPRIN1 ARHGAP33 | 4.85e-05 | 802 | 117 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SHANK1 EVL NUMBL BRSK2 BCL11A PAK6 C12orf57 DIP2A MAP1S FARP1 NKX6-1 ROBO3 BRSK1 CAPRIN1 ARHGAP33 | 6.15e-05 | 819 | 117 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | synapse assembly | 6.62e-05 | 308 | 117 | 9 | GO:0007416 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SHANK1 EVL NUMBL BRSK2 BCL11A PAK6 C12orf57 DIP2A MAP1S FARP1 NKX6-1 ROBO3 BRSK1 CAPRIN1 ARHGAP33 | 6.77e-05 | 826 | 117 | 15 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SHANK1 EVL NUMBL BRSK2 BCL11A C12orf57 DIP2A MAP1S FARP1 NKX6-1 ROBO3 BRSK1 CAPRIN1 ARHGAP33 | 8.76e-05 | 748 | 117 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in establishment of planar polarity | 9.54e-05 | 3 | 117 | 2 | GO:0090176 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse assembly | 1.12e-04 | 44 | 117 | 4 | GO:0150052 | |
| GeneOntologyBiologicalProcess | dendrite development | 1.25e-04 | 335 | 117 | 9 | GO:0016358 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 1.56e-04 | 202 | 117 | 7 | GO:0051963 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 2.00e-04 | 51 | 117 | 4 | GO:1902459 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 2.50e-04 | 54 | 117 | 4 | GO:0045663 | |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 2.53e-04 | 22 | 117 | 3 | GO:0006337 | |
| GeneOntologyBiologicalProcess | protein-DNA complex disassembly | 3.30e-04 | 24 | 117 | 3 | GO:0032986 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | NUMBL IQSEC2 ZDHHC8 DIP2A NRXN2 SETD5 FARP1 CAPRIN1 ARHGAP33 | 3.65e-04 | 387 | 117 | 9 | GO:0050807 |
| GeneOntologyBiologicalProcess | postsynapse organization | 4.19e-04 | 313 | 117 | 8 | GO:0099173 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | NUMBL IQSEC2 ZDHHC8 DIP2A NRXN2 SETD5 FARP1 CAPRIN1 ARHGAP33 | 4.23e-04 | 395 | 117 | 9 | GO:0050803 |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | FOXJ2 LILRB3 RAP1GAP RARB BICRA BCL11A ZFPM1 FOXA1 SMARCA2 SMARCA4 SMARCC1 FOXO4 NKX6-1 TP73 | 4.39e-04 | 875 | 117 | 14 | GO:0045596 |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | CDSN RAP1GAP FOXA1 FCHO1 ARID2 SMARCA2 TNFRSF13C SMARCA4 SMARCC1 TNFAIP3 MUC4 | 4.65e-04 | 580 | 117 | 11 | GO:0022407 |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 4.71e-04 | 6 | 117 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | 4.81e-04 | 402 | 117 | 9 | GO:1901990 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 5.14e-04 | 246 | 117 | 7 | GO:1902806 | |
| GeneOntologyBiologicalProcess | synapse organization | SHANK1 CABP1 NUMBL IQSEC2 ZDHHC8 DIP2A NRXN2 SETD5 FARP1 CAPRIN1 SDK1 ARHGAP33 | 5.20e-04 | 685 | 117 | 12 | GO:0050808 |
| GeneOntologyBiologicalProcess | neuron development | SHANK1 EVL NUMBL BRSK2 BCL11A PAK6 C12orf57 PRDM1 ADM DIP2A MAP1S FARP1 NKX6-1 ROBO3 BRSK1 CAPRIN1 SDK1 ARHGAP33 TP73 | 5.65e-04 | 1463 | 117 | 19 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | FOXA1 ARID2 NABP2 MEPCE SMARCA2 SMARCA4 SMARCC1 FOXO4 BRSK1 MUC1 TP73 | 5.67e-04 | 594 | 117 | 11 | GO:0007346 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | RTEL1 BRSK2 FOXA1 MISP MAP1S ARID2 NABP2 MEPCE SMARCA2 SMARCA4 SMARCC1 FOXO4 BRSK1 MUC1 TP73 | 6.16e-04 | 1014 | 117 | 15 | GO:0000278 |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | BRSK2 ARID2 NABP2 MEPCE SMARCA2 SMARCA4 SMARCC1 FOXO4 BRSK1 MUC1 | 6.47e-04 | 509 | 117 | 10 | GO:0044772 |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | ARID2 NABP2 MEPCE SMARCA2 SMARCA4 SMARCC1 FOXO4 BRSK1 MUC1 MN1 | 7.19e-04 | 516 | 117 | 10 | GO:1901987 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | NUMBL BCL11A ARID2 SMARCA2 SMARCA4 SMARCC1 NKX6-1 SPEN MYRF CAPRIN1 TP73 | 7.45e-04 | 614 | 117 | 11 | GO:0010720 |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.59e-08 | 30 | 119 | 6 | GO:0016514 | |
| GeneOntologyCellularComponent | GBAF complex | 9.56e-07 | 14 | 119 | 4 | GO:0140288 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.27e-06 | 96 | 119 | 7 | GO:0070603 | |
| GeneOntologyCellularComponent | chromatin | FOXJ2 PCGF2 RARB BICRA NKX2-6 GATA5 TSPY26P BCL11A ZFPM1 FOXA1 TBX19 SF3B1 SETD5 ARID2 SMARCA2 SMARCA4 SMARCC1 ZFHX2 FOXO4 CHD6 NKX6-1 MUC1 TP73 FOXI1 | 2.62e-06 | 1480 | 119 | 24 | GO:0000785 |
| GeneOntologyCellularComponent | ATPase complex | 9.14e-06 | 129 | 119 | 7 | GO:1904949 | |
| GeneOntologyCellularComponent | npBAF complex | 6.25e-05 | 14 | 119 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | RSC-type complex | 7.79e-05 | 15 | 119 | 3 | GO:0016586 | |
| GeneOntologyCellularComponent | nBAF complex | 9.54e-05 | 16 | 119 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | fibrillar center | 2.72e-04 | 156 | 119 | 6 | GO:0001650 | |
| GeneOntologyCellularComponent | cell cortex | CABP1 TMEM201 IQSEC2 PARD3B SHROOM2 STIM1 MISP CLTB ARHGAP33 | 2.76e-04 | 371 | 119 | 9 | GO:0005938 |
| GeneOntologyCellularComponent | cortical endoplasmic reticulum | 1.13e-03 | 9 | 119 | 2 | GO:0032541 | |
| GeneOntologyCellularComponent | nuclear matrix | 1.24e-03 | 140 | 119 | 5 | GO:0016363 | |
| GeneOntologyCellularComponent | bBAF complex | 1.40e-03 | 10 | 119 | 2 | GO:0140092 | |
| HumanPheno | Prominent interphalangeal joints | 1.44e-05 | 6 | 47 | 3 | HP:0006237 | |
| HumanPheno | Thin vermilion border | PCGF2 HIVEP2 GLIS3 NKX2-6 GATA5 BCL11A SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 MED13 | 2.08e-05 | 433 | 47 | 14 | HP:0000233 |
| HumanPheno | Abnormal nasal tip morphology | PCGF2 RARB BICRA BCL11A MED13L SNIP1 SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 | 2.90e-05 | 386 | 47 | 13 | HP:0000436 |
| HumanPheno | Thin upper lip vermilion | PCGF2 HIVEP2 GLIS3 BCL11A SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 MED13 | 3.88e-05 | 339 | 47 | 12 | HP:0000219 |
| HumanPheno | Thin lips | PCGF2 HIVEP2 GLIS3 BCL11A SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 MED13 | 3.88e-05 | 339 | 47 | 12 | HP:0000213 |
| HumanPheno | Narrow palpebral fissure | 4.05e-05 | 71 | 47 | 6 | HP:0045025 | |
| HumanPheno | Abnormality of upper lip vermillion | PCGF2 HIVEP2 IQSEC2 GLIS3 BCL11A SNIP1 SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 MED13 | 4.53e-05 | 464 | 47 | 14 | HP:0011339 |
| HumanPheno | Low anterior hairline | 4.81e-05 | 147 | 47 | 8 | HP:0000294 | |
| HumanPheno | Autistic behavior | CACNA1B PCGF2 HIVEP2 BICRA IQSEC2 BCORL1 BCL11A MED13L SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 MED13 ZMYM3 | 5.91e-05 | 678 | 47 | 17 | HP:0000729 |
| HumanPheno | Hyperactivity | CACNA1B PCGF2 HIVEP2 IQSEC2 BCORL1 MED13L SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 MED13 ZMYM3 | 8.63e-05 | 558 | 47 | 15 | HP:0000752 |
| HumanPheno | Prominent nasal tip | 1.11e-04 | 28 | 47 | 4 | HP:0005274 | |
| HumanPheno | Wide nasal base | 1.11e-04 | 28 | 47 | 4 | HP:0012810 | |
| HumanPheno | Abnormal nasal base norphology | 1.46e-04 | 30 | 47 | 4 | HP:0012808 | |
| HumanPheno | Frontal bossing | CACNA1B PCGF2 HIVEP2 BICRA IQSEC2 BCORL1 NKX2-6 GATA5 MED13L C12orf57 STIM1 SETD5 ARID2 SETBP1 SMARCA2 CHD6 SPEN | 1.74e-04 | 738 | 47 | 17 | HP:0002007 |
| HumanPheno | Abnormal shape of the frontal region | CACNA1B PCGF2 HIVEP2 BICRA IQSEC2 BCORL1 NKX2-6 GATA5 MED13L C12orf57 STIM1 SETD5 ARID2 SETBP1 SMARCA2 CHD6 SPEN | 1.83e-04 | 741 | 47 | 17 | HP:0011218 |
| HumanPheno | Abnormal frontal bone morphology | CACNA1B PCGF2 HIVEP2 BICRA IQSEC2 BCORL1 NKX2-6 GATA5 MED13L C12orf57 STIM1 SETD5 ARID2 SETBP1 SMARCA2 CHD6 SPEN | 1.86e-04 | 742 | 47 | 17 | HP:0430000 |
| HumanPheno | Diagnostic behavioral phenotype | CACNA1B PCGF2 HIVEP2 BICRA IQSEC2 BCORL1 BCL11A MED13L SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 MED13 ZMYM3 | 2.02e-04 | 747 | 47 | 17 | HP:0025783 |
| HumanPheno | Abnormal eyebrow morphology | CDSN HIVEP2 RTEL1 BICRA IQSEC2 MED13L C12orf57 SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 CHD6 SPEN MN1 MED13 | 2.06e-04 | 674 | 47 | 16 | HP:0000534 |
| HumanPheno | Abnormal external nose morphology | CACNA1B PCGF2 HIVEP2 RARB BICRA IQSEC2 BCL11A MED13L C12orf57 SNIP1 SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 CHD6 SPEN MN1 CAPRIN1 | 2.49e-04 | 916 | 47 | 19 | HP:0010938 |
| HumanPheno | Attention deficit hyperactivity disorder | CACNA1B PCGF2 IQSEC2 BCORL1 SETD5 ARID2 SETBP1 SMARCA2 SPEN CAPRIN1 MED13 ZMYM3 | 2.62e-04 | 413 | 47 | 12 | HP:0007018 |
| HumanPheno | Thin scalp hair | 2.91e-04 | 143 | 47 | 7 | HP:0002556 | |
| HumanPheno | Thin hair | 2.91e-04 | 143 | 47 | 7 | HP:0002237 | |
| HumanPheno | Sparse scalp hair | 2.91e-04 | 143 | 47 | 7 | HP:0002209 | |
| HumanPheno | Anteverted nares | CACNA1B HIVEP2 RARB BICRA IQSEC2 BCL11A SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN MN1 CAPRIN1 | 3.41e-04 | 559 | 47 | 14 | HP:0000463 |
| HumanPheno | Upturned nose | CACNA1B HIVEP2 RARB BICRA IQSEC2 BCL11A SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN MN1 CAPRIN1 | 3.41e-04 | 559 | 47 | 14 | HP:0000427 |
| HumanPheno | Synophrys | 3.47e-04 | 195 | 47 | 8 | HP:0000664 | |
| HumanPheno | Abnormality of refraction | HIVEP2 BICRA IQSEC2 MED13L C12orf57 ZNF469 SF3B1 SETD5 ARID2 SETBP1 SMARCA4 CHD6 ROBO3 SPEN CAPRIN1 ZMYM3 | 3.73e-04 | 709 | 47 | 16 | HP:0000539 |
| HumanPheno | Abnormal morphology of the nasal alae | CACNA1B HIVEP2 RARB BICRA IQSEC2 BCL11A SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 CHD6 SPEN MN1 CAPRIN1 | 3.99e-04 | 639 | 47 | 15 | HP:0000429 |
| HumanPheno | Brachycephaly | 4.12e-04 | 253 | 47 | 9 | HP:0000248 | |
| HumanPheno | Abnormal nostril morphology | CACNA1B HIVEP2 RARB BICRA IQSEC2 BCL11A SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN MN1 CAPRIN1 | 4.58e-04 | 575 | 47 | 14 | HP:0005288 |
| HumanPheno | Abnormality of calvarial morphology | CACNA1B PCGF2 HIVEP2 BICRA IQSEC2 BCORL1 GLIS3 NKX2-6 GATA5 MED13L C12orf57 STIM1 SETD5 ARID2 SETBP1 SMARCA2 TNFRSF13C CHD6 ROBO3 SPEN MN1 | 5.00e-04 | 1134 | 47 | 21 | HP:0002648 |
| HumanPheno | Facial hypertrichosis | 5.03e-04 | 206 | 47 | 8 | HP:0002219 | |
| HumanPheno | Disinhibition | CACNA1B PCGF2 HIVEP2 IQSEC2 BCORL1 BCL11A MED13L C12orf57 SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 MED13 ZMYM3 | 5.20e-04 | 807 | 47 | 17 | HP:0000734 |
| HumanPheno | Inappropriate behavior | CACNA1B PCGF2 HIVEP2 IQSEC2 BCORL1 BCL11A MED13L C12orf57 SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 MED13 ZMYM3 | 5.20e-04 | 807 | 47 | 17 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | CACNA1B PCGF2 HIVEP2 IQSEC2 BCORL1 BCL11A MED13L C12orf57 SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 MED13 ZMYM3 | 5.20e-04 | 807 | 47 | 17 | HP:5200123 |
| HumanPheno | Social disinhibition | CACNA1B PCGF2 HIVEP2 IQSEC2 BCORL1 BCL11A MED13L C12orf57 SETD5 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 MED13 ZMYM3 | 5.20e-04 | 807 | 47 | 17 | HP:5200029 |
| HumanPheno | Myopia | BICRA IQSEC2 MED13L C12orf57 ZNF469 SETD5 ARID2 SETBP1 SMARCA4 CHD6 CAPRIN1 ZMYM3 | 5.44e-04 | 447 | 47 | 12 | HP:0000545 |
| HumanPheno | Aggressive behavior | CACNA1B HIVEP2 IQSEC2 BCORL1 BCL11A MED13L C12orf57 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 | 5.59e-04 | 516 | 47 | 13 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | CACNA1B HIVEP2 IQSEC2 BCORL1 BCL11A MED13L C12orf57 ARID2 SETBP1 SMARCA2 SMARCA4 SPEN CAPRIN1 | 5.59e-04 | 516 | 47 | 13 | HP:0006919 |
| HumanPheno | Abnormality of the frontal hairline | 6.69e-04 | 215 | 47 | 8 | HP:0000599 | |
| HumanPheno | Macrostomia | 7.79e-04 | 220 | 47 | 8 | HP:0000181 | |
| HumanPheno | Wide mouth | 7.79e-04 | 220 | 47 | 8 | HP:0000154 | |
| HumanPheno | Mild short stature | 8.72e-04 | 21 | 47 | 3 | HP:0003502 | |
| Domain | BRK | 4.61e-06 | 6 | 116 | 3 | SM00592 | |
| Domain | BRK_domain | 4.61e-06 | 6 | 116 | 3 | IPR006576 | |
| Domain | BRK | 4.61e-06 | 6 | 116 | 3 | PF07533 | |
| Domain | ZINC_FINGER_C2H2_2 | HIVEP1 HIVEP2 ZNF628 GLIS3 HIC2 ZKSCAN7 ZNF395 BCL11A ZFPM1 PRDM1 ZNF469 SALL2 ARID2 ZBTB40 ZFHX2 ZNF687 | 2.38e-05 | 775 | 116 | 16 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | HIVEP1 HIVEP2 ZNF628 GLIS3 HIC2 ZKSCAN7 ZNF395 BCL11A ZFPM1 PRDM1 ZNF469 SALL2 ARID2 ZBTB40 ZFHX2 ZNF687 | 2.46e-05 | 777 | 116 | 16 | PS00028 |
| Domain | zf-C2H2 | HIVEP1 HIVEP2 ZNF628 GLIS3 HIC2 ZKSCAN7 ZNF395 BCL11A ZFPM1 PRDM1 ZNF469 SALL2 ZBTB40 ZFHX2 ZNF687 | 2.54e-05 | 693 | 116 | 15 | PF00096 |
| Domain | Znf_C2H2-like | HIVEP1 HIVEP2 ZNF628 GLIS3 HIC2 ZKSCAN7 ZNF395 BCL11A ZFPM1 PRDM1 ZNF469 SALL2 ARID2 ZBTB40 ZFHX2 ZNF687 | 3.29e-05 | 796 | 116 | 16 | IPR015880 |
| Domain | Znf_C2H2 | HIVEP1 HIVEP2 ZNF628 GLIS3 HIC2 ZKSCAN7 ZNF395 BCL11A ZFPM1 PRDM1 ZNF469 SALL2 ARID2 ZBTB40 ZFHX2 ZNF687 | 3.77e-05 | 805 | 116 | 16 | IPR007087 |
| Domain | SnAC | 3.82e-05 | 2 | 116 | 2 | SM01314 | |
| Domain | Gln-Leu-Gln_QLQ | 3.82e-05 | 2 | 116 | 2 | IPR014978 | |
| Domain | SnAC | 3.82e-05 | 2 | 116 | 2 | IPR029295 | |
| Domain | SnAC | 3.82e-05 | 2 | 116 | 2 | PF14619 | |
| Domain | Med13_N | 3.82e-05 | 2 | 116 | 2 | PF11597 | |
| Domain | QLQ | 3.82e-05 | 2 | 116 | 2 | SM00951 | |
| Domain | Mediator_Med13_N_met/fun | 3.82e-05 | 2 | 116 | 2 | IPR021643 | |
| Domain | Mediator_Med13 | 3.82e-05 | 2 | 116 | 2 | IPR009401 | |
| Domain | QLQ | 3.82e-05 | 2 | 116 | 2 | PS51666 | |
| Domain | Med13_C | 3.82e-05 | 2 | 116 | 2 | PF06333 | |
| Domain | QLQ | 3.82e-05 | 2 | 116 | 2 | PF08880 | |
| Domain | ZnF_C2H2 | HIVEP1 HIVEP2 ZNF628 GLIS3 HIC2 ZKSCAN7 ZNF395 BCL11A ZFPM1 PRDM1 ZNF469 SALL2 ARID2 ZBTB40 ZFHX2 ZNF687 | 3.94e-05 | 808 | 116 | 16 | SM00355 |
| Domain | Znf_C2H2/integrase_DNA-bd | HIVEP1 HIVEP2 ZNF628 GLIS3 HIC2 ZKSCAN7 BCL11A ZFPM1 PRDM1 ZNF469 SALL2 ZBTB40 ZFHX2 ZNF687 | 1.02e-04 | 694 | 116 | 14 | IPR013087 |
| Domain | TF_fork_head_CS_2 | 1.88e-04 | 46 | 116 | 4 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 2.05e-04 | 47 | 116 | 4 | IPR018122 | |
| Domain | HSA | 2.28e-04 | 4 | 116 | 2 | SM00573 | |
| Domain | HSA | 2.28e-04 | 4 | 116 | 2 | PS51204 | |
| Domain | HSA_dom | 2.28e-04 | 4 | 116 | 2 | IPR014012 | |
| Domain | HSA | 2.28e-04 | 4 | 116 | 2 | PF07529 | |
| Domain | FH | 2.41e-04 | 49 | 116 | 4 | SM00339 | |
| Domain | FORK_HEAD_1 | 2.41e-04 | 49 | 116 | 4 | PS00657 | |
| Domain | FORK_HEAD_2 | 2.41e-04 | 49 | 116 | 4 | PS00658 | |
| Domain | Fork_head_dom | 2.41e-04 | 49 | 116 | 4 | IPR001766 | |
| Domain | FORK_HEAD_3 | 2.41e-04 | 49 | 116 | 4 | PS50039 | |
| Domain | Forkhead | 2.41e-04 | 49 | 116 | 4 | PF00250 | |
| Domain | SNF2_N | 1.02e-03 | 32 | 116 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.02e-03 | 32 | 116 | 3 | PF00176 | |
| Domain | - | HIVEP1 HIVEP2 ZNF628 GLIS3 HIC2 ZKSCAN7 BCL11A ZFPM1 PRDM1 SALL2 ZBTB40 ZFHX2 | 1.05e-03 | 679 | 116 | 12 | 3.30.160.60 |
| Domain | - | 2.41e-03 | 218 | 116 | 6 | 1.10.10.10 | |
| Domain | SEA | 3.31e-03 | 14 | 116 | 2 | SM00200 | |
| Domain | - | 3.81e-03 | 15 | 116 | 2 | 3.30.70.960 | |
| Domain | WHTH_DNA-bd_dom | 4.04e-03 | 242 | 116 | 6 | IPR011991 | |
| Domain | VWD | 4.34e-03 | 16 | 116 | 2 | SM00216 | |
| Domain | VWF_type-D | 4.34e-03 | 16 | 116 | 2 | IPR001846 | |
| Domain | VWFD | 4.34e-03 | 16 | 116 | 2 | PS51233 | |
| Domain | VWD | 4.34e-03 | 16 | 116 | 2 | PF00094 | |
| Domain | p53-like_TF_DNA-bd | 4.36e-03 | 53 | 116 | 3 | IPR008967 | |
| Domain | Helicase_C | 4.46e-03 | 107 | 116 | 4 | PF00271 | |
| Domain | HELICc | 4.46e-03 | 107 | 116 | 4 | SM00490 | |
| Domain | Helicase_C | 4.61e-03 | 108 | 116 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 4.76e-03 | 109 | 116 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.76e-03 | 109 | 116 | 4 | PS51192 | |
| Domain | DEXDc | 4.76e-03 | 109 | 116 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 4.92e-03 | 110 | 116 | 4 | IPR014001 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.93e-06 | 16 | 83 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.51e-06 | 17 | 83 | 4 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 6.20e-06 | 21 | 83 | 4 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 9.08e-06 | 23 | 83 | 4 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.51e-05 | 26 | 83 | 4 | M27483 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 6.36e-05 | 37 | 83 | 4 | M27797 | |
| Pathway | WP_RETT_SYNDROME | 1.78e-04 | 48 | 83 | 4 | M39759 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 2.81e-04 | 153 | 83 | 6 | M39546 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 4.24e-04 | 60 | 83 | 4 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 4.81e-04 | 62 | 83 | 4 | M546 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 6.44e-04 | 29 | 83 | 3 | M48076 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.83e-04 | 68 | 83 | 4 | M27303 | |
| Pathway | WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS | 1.12e-03 | 35 | 83 | 3 | M39430 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 1.12e-03 | 35 | 83 | 3 | M47969 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 1.14e-03 | 78 | 83 | 4 | M27234 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXJ2 HIVEP1 HIVEP2 RARB HIC2 NKX2-6 ZNF395 GATA5 ZFPM1 FOXA1 ZC3H3 PRDM1 TBX19 SALL2 SETBP1 TOX3 ZFHX2 FOXO4 NKX6-1 MYRF TP73 FOXI1 | 7.72e-13 | 908 | 121 | 22 | 19274049 |
| Pubmed | BICRA FBF1 PHRF1 FBRSL1 HIC2 BCL11A FOXA1 NCKAP5L ZC3H3 SNIP1 ZNF469 SALL2 SETD5 ARID2 PIP4K2A MEPCE SMARCA2 SMARCA4 SMARCC1 ZMYM3 ARHGAP33 ZNF687 TP73 | 5.90e-12 | 1116 | 121 | 23 | 31753913 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | HIVEP1 HIVEP2 BICRA BCORL1 FBRSL1 BCL11A MED15 TNRC18 ARID2 SMARCA2 SMARCA4 SMARCC1 SPEN ZMYM3 | 2.51e-11 | 351 | 121 | 14 | 38297188 |
| Pubmed | HIVEP1 BICRA NACA BCORL1 FBRSL1 HIC2 BCL11A FOXA1 PRDM1 MED15 SALL2 ARID2 NFKBIE SMARCA2 ZBTB40 SMARCA4 SMARCC1 CHD6 SPEN CAPRIN1 ZMYM3 ZNF687 FOXI1 | 7.66e-10 | 1429 | 121 | 23 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIVEP2 ZNF628 BICRA AOC2 FBRSL1 ZNF395 ZFPM1 MED13L ZDHHC8 DIP2A TNRC18 MAP1S SETD5 TNFAIP3 LRBA SPEN MYRF MED13 ARHGAP33 ZNF687 | 1.57e-09 | 1105 | 121 | 20 | 35748872 |
| Pubmed | FOXJ2 PCGF2 HIVEP1 HIVEP2 RARB BCL11A FOXA1 SALL2 NFKBIE SMARCA2 SMARCA4 SMARCC1 ZFHX2 FOXO4 ZMYM3 ZNF687 | 3.70e-09 | 709 | 121 | 16 | 22988430 | |
| Pubmed | EVL HIVEP1 DDX49 BICRA BCORL1 BCL11A MED13L MED15 TNRC18 ARID2 CLTB SMARCA2 ZBTB40 SMARCA4 SMARCC1 SPEN CAPRIN1 ZMYM3 ZNF687 | 9.34e-09 | 1103 | 121 | 19 | 34189442 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | HIVEP1 BICRA BCORL1 FBRSL1 NCKAP5L MED15 TNRC18 ARID2 PIP4K2A SMARCA2 SMARCA4 SMARCC1 | 1.63e-08 | 398 | 121 | 12 | 35016035 |
| Pubmed | SHANK1 HIVEP1 HIVEP2 BICRA PAK6 NCKAP5L SF3B1 SYNJ2 ARID2 CHD6 TNFAIP3 MUC1 ARHGAP33 | 1.65e-08 | 486 | 121 | 13 | 20936779 | |
| Pubmed | 3.56e-08 | 27 | 121 | 5 | 29374058 | ||
| Pubmed | HIVEP1 MED13L FOXA1 MED15 TNRC18 MEPCE SMARCA2 SMARCA4 SMARCC1 MED13 | 3.73e-08 | 268 | 121 | 10 | 33640491 | |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 23053434 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 27483328 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 24939955 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 23446997 | ||
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 4.11e-08 | 3 | 121 | 3 | 17592322 | |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 35879412 | ||
| Pubmed | 5.21e-08 | 29 | 121 | 5 | 19279220 | ||
| Pubmed | 7.78e-08 | 103 | 121 | 7 | 32744500 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EVL HIVEP1 PHRF1 ZFPM1 SF3B1 MAP1S SMARCA2 ZBTB40 SMARCA4 SMARCC1 SPEN MN1 MED13 ZMYM3 ZNF687 | 8.65e-08 | 774 | 121 | 15 | 15302935 |
| Pubmed | Neurogenin3 cooperates with Foxa2 to autoactivate its own expression. | 9.73e-08 | 13 | 121 | 4 | 23471965 | |
| Pubmed | 1.01e-07 | 107 | 121 | 7 | 11347906 | ||
| Pubmed | Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. | 1.36e-07 | 14 | 121 | 4 | 8895581 | |
| Pubmed | 1.36e-07 | 14 | 121 | 4 | 30510198 | ||
| Pubmed | DNA Damage Regulates Translation through β-TRCP Targeting of CReP. | 1.40e-07 | 35 | 121 | 5 | 26091241 | |
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 1.64e-07 | 4 | 121 | 3 | 39024979 | |
| Pubmed | Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation. | 1.64e-07 | 4 | 121 | 3 | 24421395 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 16452305 | ||
| Pubmed | Mitotic inactivation of a human SWI/SNF chromatin remodeling complex. | 1.64e-07 | 4 | 121 | 3 | 9744861 | |
| Pubmed | 1.85e-07 | 15 | 121 | 4 | 9891079 | ||
| Pubmed | 3.20e-07 | 17 | 121 | 4 | 11078522 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SPATA31E1 BICRA GLIS3 ZNF469 TNRC18 MAP1S ARID2 SETBP1 SPEN TP73 FOXI1 | 3.43e-07 | 430 | 121 | 11 | 35044719 |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 4.09e-07 | 5 | 121 | 3 | 16475027 | |
| Pubmed | Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). | 4.09e-07 | 5 | 121 | 3 | 9843504 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 4.11e-07 | 18 | 121 | 4 | 18834073 | |
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 5.19e-07 | 19 | 121 | 4 | 12110891 | |
| Pubmed | 6.47e-07 | 20 | 121 | 4 | 9128241 | ||
| Pubmed | A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. | 8.15e-07 | 6 | 121 | 3 | 10619021 | |
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 16940996 | ||
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 16230384 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EVL HIVEP2 NUMBL RTEL1 BICRA FBRSL1 PARD3B SHROOM2 TNRC18 SYNJ2 SETD5 SIGIRR FARP1 SETBP1 TOX3 SMARCA2 ZFHX2 CHD6 LRBA | 9.65e-07 | 1489 | 121 | 19 | 28611215 |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 1.17e-06 | 23 | 121 | 4 | 30962207 | |
| Pubmed | 1.17e-06 | 23 | 121 | 4 | 9225980 | ||
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 1.17e-06 | 23 | 121 | 4 | 8804307 | |
| Pubmed | 1.30e-06 | 225 | 121 | 8 | 12168954 | ||
| Pubmed | 1.40e-06 | 24 | 121 | 4 | 11790558 | ||
| Pubmed | Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. | 1.40e-06 | 24 | 121 | 4 | 10078207 | |
| Pubmed | 1.40e-06 | 24 | 121 | 4 | 12215535 | ||
| Pubmed | BRIT1/MCPH1 links chromatin remodelling to DNA damage response. | 1.42e-06 | 7 | 121 | 3 | 19525936 | |
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 17074803 | ||
| Pubmed | 1.70e-06 | 57 | 121 | 5 | 21555454 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAP1GAP HIVEP1 HIVEP2 NUMBL IQSEC2 BRSK2 PARD3B PAK6 NCKAP5L STIM1 SYNJ2 MEPCE FOXO4 TNFAIP3 | 1.91e-06 | 861 | 121 | 14 | 36931259 |
| Pubmed | 1.96e-06 | 26 | 121 | 4 | 10778858 | ||
| Pubmed | 2.27e-06 | 8 | 121 | 3 | 18042045 | ||
| Pubmed | CHD7 cooperates with PBAF to control multipotent neural crest formation. | 2.27e-06 | 8 | 121 | 3 | 20130577 | |
| Pubmed | 2.27e-06 | 8 | 121 | 3 | 26986003 | ||
| Pubmed | SHANK1 EVL RAP1GAP NUMBL IQSEC2 BRSK2 BCL11A SHROOM2 DIP2A MISP SF3B1 MAP1S NRXN2 FARP1 PIP4K2A SMARCA4 BRSK1 CAPRIN1 | 2.35e-06 | 1431 | 121 | 18 | 37142655 | |
| Pubmed | SHANK1 RAP1GAP PCGF2 HIVEP2 RARB IQSEC2 MED13L SHROOM2 DIP2A SF3B1 MAP1S NABP2 SMARCA4 CHD6 LRBA CAPRIN1 MED13 | 2.36e-06 | 1285 | 121 | 17 | 35914814 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | FOXJ2 PCGF2 HIVEP2 RARB GLIS3 ZKSCAN7 GATA5 FOXA1 TBX19 CIITA TOX3 TNFAIP3 SPEN TP73 | 2.37e-06 | 877 | 121 | 14 | 20211142 |
| Pubmed | 2.39e-06 | 61 | 121 | 5 | 20305087 | ||
| Pubmed | HIVEP1 FBF1 BCORL1 FBRSL1 MUC16 MED15 ARID2 SMARCA2 SMARCC1 CHD6 SPEN ZNF687 | 2.49e-06 | 638 | 121 | 12 | 31182584 | |
| Pubmed | REST repression of neuronal genes requires components of the hSWI.SNF complex. | 2.68e-06 | 28 | 121 | 4 | 12192000 | |
| Pubmed | 3.09e-06 | 29 | 121 | 4 | 36800290 | ||
| Pubmed | 4.84e-06 | 10 | 121 | 3 | 16192310 | ||
| Pubmed | Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. | 4.84e-06 | 10 | 121 | 3 | 11238380 | |
| Pubmed | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. | 4.84e-06 | 10 | 121 | 3 | 23746844 | |
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 4.84e-06 | 10 | 121 | 3 | 23129809 | |
| Pubmed | Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. | 6.64e-06 | 11 | 121 | 3 | 10204490 | |
| Pubmed | Targeting HIV transcription: the quest for a functional cure. | 6.64e-06 | 11 | 121 | 3 | 25731772 | |
| Pubmed | 6.64e-06 | 11 | 121 | 3 | 22334708 | ||
| Pubmed | 6.71e-06 | 35 | 121 | 4 | 32504627 | ||
| Pubmed | 6.90e-06 | 282 | 121 | 8 | 23667531 | ||
| Pubmed | 8.42e-06 | 37 | 121 | 4 | 24335282 | ||
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 15140983 | ||
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 11734557 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXJ2 HIC2 FOXA1 SALL2 SF3B1 ZBTB40 SMARCA4 SMARCC1 FOXO4 NKX6-1 SPEN ZMYM3 FOXI1 | 9.58e-06 | 857 | 121 | 13 | 25609649 |
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 17340523 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 1.16e-05 | 40 | 121 | 4 | 34585037 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 8670841 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22245845 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23163725 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 1.20e-05 | 2 | 121 | 2 | 23076393 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 16194893 | ||
| Pubmed | Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML. | 1.20e-05 | 2 | 121 | 2 | 33974912 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28885228 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15576411 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15240517 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 1.20e-05 | 2 | 121 | 2 | 33027072 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23872584 | ||
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 1.20e-05 | 2 | 121 | 2 | 23088494 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 30011875 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 20333683 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34812766 | ||
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 1.20e-05 | 2 | 121 | 2 | 30478150 | |
| Pubmed | HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription. | 1.20e-05 | 2 | 121 | 2 | 35941187 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23001124 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 25531720 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 20598042 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27003157 | ||
| Interaction | TLE3 interactions | FOXJ2 HIVEP1 HIVEP2 BCORL1 FBRSL1 FOXA1 PRDM1 MED15 TNRC18 ARID2 SMARCA4 CHD6 SPEN FOXI1 | 4.89e-08 | 376 | 119 | 14 | int:TLE3 |
| Interaction | EGR2 interactions | HIVEP1 HIVEP2 BICRA BCORL1 FBRSL1 BCL11A TNRC18 ARID2 SMARCA2 SMARCC1 | 7.13e-08 | 171 | 119 | 10 | int:EGR2 |
| Interaction | ASF1A interactions | HIVEP1 BICRA BCORL1 SALL2 ARID2 SMARCA4 SMARCC1 CHD6 SPEN ZNF687 TP73 | 2.68e-07 | 249 | 119 | 11 | int:ASF1A |
| Interaction | CRX interactions | BICRA BCORL1 FBRSL1 MED15 TNRC18 ARID2 SMARCA2 SMARCC1 SPEN ZMYM3 | 2.71e-06 | 254 | 119 | 10 | int:CRX |
| Interaction | ETS1 interactions | 7.59e-06 | 121 | 119 | 7 | int:ETS1 | |
| Interaction | NFIX interactions | 8.24e-06 | 227 | 119 | 9 | int:NFIX | |
| Interaction | BRD2 interactions | BICRA FBRSL1 ZC3H3 SNIP1 FARP1 ARID2 PIP4K2A MEPCE SMARCA2 SMARCA4 SMARCC1 ZNF687 | 9.03e-06 | 429 | 119 | 12 | int:BRD2 |
| Interaction | SOX7 interactions | 9.07e-06 | 82 | 119 | 6 | int:SOX7 | |
| Interaction | PAX6 interactions | HIVEP1 BICRA FBRSL1 MISP ARID2 SMARCA2 SMARCA4 SMARCC1 CHD6 ZMYM3 TP73 | 1.12e-05 | 366 | 119 | 11 | int:PAX6 |
| Interaction | SMARCD2 interactions | 1.32e-05 | 183 | 119 | 8 | int:SMARCD2 | |
| Interaction | YWHAE interactions | RAP1GAP HIVEP1 HIVEP2 NUMBL IQSEC2 DOK3 BRSK2 PARD3B ZNF395 PAK6 SHROOM2 NCKAP5L STIM1 SF3B1 SYNJ2 MEPCE TNFAIP3 LRBA BRSK1 CAPRIN1 ARHGAP33 | 1.34e-05 | 1256 | 119 | 21 | int:YWHAE |
| Interaction | SS18 interactions | 1.36e-05 | 88 | 119 | 6 | int:SS18 | |
| Interaction | PRMT2 interactions | 1.65e-05 | 91 | 119 | 6 | int:PRMT2 | |
| Interaction | DPF3 interactions | 2.11e-05 | 95 | 119 | 6 | int:DPF3 | |
| Interaction | DPF1 interactions | 2.11e-05 | 95 | 119 | 6 | int:DPF1 | |
| Interaction | GATA2 interactions | 2.41e-05 | 199 | 119 | 8 | int:GATA2 | |
| Interaction | FEV interactions | 2.78e-05 | 203 | 119 | 8 | int:FEV | |
| Interaction | RCOR1 interactions | HIVEP1 BCORL1 NCKAP5L PRDM1 SALL2 SMARCA4 SMARCC1 CHD6 LRBA SPEN ZMYM3 ZNF687 | 3.64e-05 | 494 | 119 | 12 | int:RCOR1 |
| Interaction | ARID1A interactions | 3.87e-05 | 276 | 119 | 9 | int:ARID1A | |
| Interaction | CEBPA interactions | EVL HIVEP1 DDX49 RARB BICRA BCORL1 BCL11A MED13L MED15 TNRC18 ARID2 CLTB SMARCA2 ZBTB40 SMARCA4 SMARCC1 SPEN CAPRIN1 ZMYM3 ZNF687 | 3.92e-05 | 1245 | 119 | 20 | int:CEBPA |
| Interaction | SMARCD3 interactions | 4.15e-05 | 107 | 119 | 6 | int:SMARCD3 | |
| Interaction | TOP3B interactions | HIVEP2 ZNF628 RTEL1 BICRA AOC2 FBRSL1 ZNF395 ZFPM1 MED13L ZDHHC8 DIP2A TNRC18 MAP1S SETD5 TNFAIP3 LRBA SPEN MYRF CAPRIN1 MED13 ARHGAP33 ZNF687 | 4.47e-05 | 1470 | 119 | 22 | int:TOP3B |
| Interaction | BICRA interactions | 4.76e-05 | 67 | 119 | 5 | int:BICRA | |
| Interaction | HDAC2 interactions | FOXJ2 BCL11A ZFPM1 PRDM1 STIM1 CIITA MEPCE SMARCA2 SMARCA4 SMARCC1 LRBA SPEN CAPRIN1 ZMYM3 ZNF687 TP73 | 4.95e-05 | 865 | 119 | 16 | int:HDAC2 |
| Interaction | CDK8 interactions | 5.25e-05 | 222 | 119 | 8 | int:CDK8 | |
| Interaction | BCL7C interactions | 6.22e-05 | 115 | 119 | 6 | int:BCL7C | |
| Interaction | KLF3 interactions | 6.34e-05 | 228 | 119 | 8 | int:KLF3 | |
| Interaction | TBXT interactions | 6.53e-05 | 116 | 119 | 6 | int:TBXT | |
| Interaction | MED16 interactions | 7.89e-05 | 120 | 119 | 6 | int:MED16 | |
| Interaction | SS18L2 interactions | 8.72e-05 | 76 | 119 | 5 | int:SS18L2 | |
| Interaction | ARID1B interactions | 8.77e-05 | 177 | 119 | 7 | int:ARID1B | |
| Interaction | PPARG interactions | 8.78e-05 | 307 | 119 | 9 | int:PPARG | |
| Interaction | BCL7A interactions | 9.04e-05 | 123 | 119 | 6 | int:BCL7A | |
| Interaction | LHX2 interactions | 1.08e-04 | 183 | 119 | 7 | int:LHX2 | |
| Interaction | MED18 interactions | 1.18e-04 | 81 | 119 | 5 | int:MED18 | |
| Interaction | STK11IP interactions | 1.33e-04 | 83 | 119 | 5 | int:STK11IP | |
| Interaction | KLF8 interactions | 1.48e-04 | 329 | 119 | 9 | int:KLF8 | |
| Interaction | RBBP4 interactions | BCL11A ZFPM1 FOXA1 MED15 TNRC18 MEPCE SMARCA2 SMARCA4 SMARCC1 SPEN CAPRIN1 ZMYM3 | 1.49e-04 | 573 | 119 | 12 | int:RBBP4 |
| Interaction | ESRRB interactions | 1.66e-04 | 262 | 119 | 8 | int:ESRRB | |
| Interaction | BRD3 interactions | BICRA FOXA1 MED15 SNIP1 SETD5 PIP4K2A MEPCE SMARCA2 SMARCA4 SMARCC1 ZNF687 | 1.67e-04 | 494 | 119 | 11 | int:BRD3 |
| Interaction | PHF10 interactions | 1.77e-04 | 139 | 119 | 6 | int:PHF10 | |
| Interaction | NR3C1 interactions | FOXJ2 HIVEP1 RARB FBF1 BCORL1 FBRSL1 MUC16 MED15 ARID2 CLTB SMARCA2 SMARCA4 SMARCC1 CHD6 SPEN ZNF687 | 1.96e-04 | 974 | 119 | 16 | int:NR3C1 |
| Interaction | LILRA6 interactions | 2.06e-04 | 4 | 119 | 2 | int:LILRA6 | |
| Interaction | SMARCA2 interactions | BICRA SNIP1 CIITA ARID2 SMARCA2 SMARCA4 SMARCC1 ARHGAP33 FOXI1 | 2.16e-04 | 346 | 119 | 9 | int:SMARCA2 |
| Interaction | SP100 interactions | 2.24e-04 | 206 | 119 | 7 | int:SP100 | |
| Interaction | HNF4A interactions | 2.31e-04 | 275 | 119 | 8 | int:HNF4A | |
| Interaction | SMARCC2 interactions | BICRA FOXA1 SNIP1 ARID2 MEPCE SMARCA2 SMARCA4 SMARCC1 CAPRIN1 | 2.50e-04 | 353 | 119 | 9 | int:SMARCC2 |
| Interaction | NFIC interactions | 2.52e-04 | 210 | 119 | 7 | int:NFIC | |
| Interaction | HDAC1 interactions | HIVEP1 RARB ZNF395 BCL11A ZFPM1 PRDM1 TNRC18 CIITA SMARCA2 SMARCA4 SMARCC1 LRBA SPEN CAPRIN1 ZMYM3 ZNF687 TP73 | 2.73e-04 | 1108 | 119 | 17 | int:HDAC1 |
| Interaction | SOX9 interactions | 2.76e-04 | 97 | 119 | 5 | int:SOX9 | |
| Interaction | SS18L1 interactions | 2.89e-04 | 98 | 119 | 5 | int:SS18L1 | |
| Interaction | SMARCE1 interactions | 3.07e-04 | 287 | 119 | 8 | int:SMARCE1 | |
| Interaction | NUP43 interactions | HIVEP1 PHRF1 STIM1 SALL2 ARID2 TOX3 SMARCA4 SMARCC1 CHD6 SPEN ZMYM3 ZNF687 | 3.29e-04 | 625 | 119 | 12 | int:NUP43 |
| Interaction | MED6 interactions | 3.33e-04 | 101 | 119 | 5 | int:MED6 | |
| Interaction | SEC14L5 interactions | 3.42e-04 | 5 | 119 | 2 | int:SEC14L5 | |
| Interaction | ERG interactions | 3.63e-04 | 223 | 119 | 7 | int:ERG | |
| Interaction | YY1 interactions | FOXJ2 PCGF2 HIVEP1 SNIP1 ARID2 PIP4K2A MEPCE SMARCA4 ZMYM3 ZNF687 | 3.64e-04 | 454 | 119 | 10 | int:YY1 |
| Interaction | CDRT15P3 interactions | 3.71e-04 | 24 | 119 | 3 | int:CDRT15P3 | |
| Interaction | YWHAG interactions | RAP1GAP HIVEP1 HIVEP2 NUMBL IQSEC2 PARD3B ZNF395 PAK6 SHROOM2 NCKAP5L STIM1 SNIP1 SYNJ2 MEPCE FOXO4 TNFAIP3 LRBA ZMYM3 | 3.77e-04 | 1248 | 119 | 18 | int:YWHAG |
| Interaction | LHX6 interactions | 3.83e-04 | 58 | 119 | 4 | int:LHX6 | |
| Interaction | LHX4 interactions | 4.60e-04 | 166 | 119 | 6 | int:LHX4 | |
| Interaction | SAP30 interactions | 4.74e-04 | 167 | 119 | 6 | int:SAP30 | |
| Interaction | FLI1 interactions | 4.95e-04 | 62 | 119 | 4 | int:FLI1 | |
| Interaction | ZCCHC10 interactions | 5.09e-04 | 236 | 119 | 7 | int:ZCCHC10 | |
| Cytoband | 11p15.5 | 1.61e-05 | 118 | 121 | 5 | 11p15.5 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | HIVEP1 HIVEP2 ZNF628 GLIS3 HIC2 ZKSCAN7 ZNF395 BCL11A ZFPM1 PRDM1 ZNF469 SALL2 ZBTB40 ZFHX2 | 1.07e-06 | 718 | 74 | 14 | 28 |
| GeneFamily | CD molecules|Mucins | 1.47e-06 | 21 | 74 | 4 | 648 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.06e-06 | 25 | 74 | 4 | 775 | |
| GeneFamily | Forkhead boxes | 2.83e-05 | 43 | 74 | 4 | 508 | |
| GeneFamily | Cyclins|Mediator complex | 3.29e-04 | 33 | 74 | 3 | 1061 | |
| GeneFamily | Fibronectin type III domain containing | 4.20e-03 | 160 | 74 | 4 | 555 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 7.16e-10 | 97 | 121 | 9 | M14698 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | FOXJ2 EVL LILRB3 BICRA LILRA6 HIC2 ZC3H3 ZDHHC8 C6orf136 DIP2A KRBA1 SF3B1 ZBTB40 SMARCA4 SPEN ARHGAP33 | 3.88e-08 | 634 | 121 | 16 | M40866 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G3 | 4.17e-07 | 14 | 121 | 4 | M8463 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | FOXJ2 EVL LILRB3 TCAF1 BICRA LILRA6 HIC2 ZC3H3 ZDHHC8 C6orf136 DIP2A KRBA1 SF3B1 ZBTB40 SMARCA4 SPEN ARHGAP33 | 9.25e-07 | 905 | 121 | 17 | M40865 |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP | 3.98e-05 | 199 | 121 | 7 | M7414 | |
| Coexpression | LIAO_METASTASIS | TMEM201 NUMBL NACA BCORL1 HIC2 BCL11A ZC3H3 FARP1 CLTB TOX3 ZMYM3 | 4.25e-05 | 540 | 121 | 11 | M13809 |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 5.04e-05 | 141 | 121 | 6 | M39235 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE | 5.46e-05 | 368 | 121 | 9 | M41100 | |
| Coexpression | DELACROIX_RAR_BOUND_ES | 6.14e-05 | 465 | 121 | 10 | M2466 | |
| Coexpression | VANTVEER_BREAST_CANCER_ESR1_UP | 6.85e-05 | 149 | 121 | 6 | M393 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP | HIVEP1 HIVEP2 AOC2 LILRA6 ADM SNIP1 NFKBIE SMARCA4 TNFAIP3 MUC6 | 8.84e-05 | 486 | 121 | 10 | M34018 |
| Coexpression | DELACROIX_RAR_BOUND_ES | 9.94e-05 | 493 | 121 | 10 | MM1079 | |
| Coexpression | BENPORATH_ES_CORE_NINE_CORRELATED | 1.02e-04 | 100 | 121 | 5 | M14079 | |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_PARTIAL | 1.16e-04 | 164 | 121 | 6 | M2502 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | HIVEP1 PARD3B MED13L SYNJ2 SETD5 ARID2 TOX3 CHD6 LRBA SDK1 MED13 | 5.75e-12 | 193 | 121 | 11 | e6a688bc834f845ff64dae1be64f073eec5091a1 |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.91e-09 | 192 | 121 | 9 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C|TCGA-Thymus / Sample_Type by Project: Shred V9 | 3.21e-07 | 163 | 121 | 7 | 2dac87d15051151ccf193760ddd8b82534c3f922 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.94e-07 | 168 | 121 | 7 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.10e-07 | 169 | 121 | 7 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.67e-07 | 192 | 121 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-06 | 198 | 121 | 7 | 5dd2aa7684c36beffa204ca4c04d0501cabac10f | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-06 | 199 | 121 | 7 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-06 | 199 | 121 | 7 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-06 | 164 | 121 | 6 | d2b5f51af7fcffddebe997ee302bacbd85d76852 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-06 | 166 | 121 | 6 | c0af93db981dfd448abc7efcd257f3e5ff066aae | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-06 | 167 | 121 | 6 | 1248f809afbcccb42ce9e29cfe6fa1f6f6b65005 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-06 | 167 | 121 | 6 | a66552667aa6e8992c159df27a57c2e8ae14a9ce | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.16e-06 | 174 | 121 | 6 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.16e-06 | 174 | 121 | 6 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-05 | 183 | 121 | 6 | af14da45267261e775dd6dab7a4c359b181e46f1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-05 | 184 | 121 | 6 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Tuft-Tuft|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-05 | 185 | 121 | 6 | 1fbdc96da0623c3935ae9d29dcb4ba9c474e5c21 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Tuft|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-05 | 185 | 121 | 6 | b45487daac116e3d3d65ac2b0f81d1bf7d1a1914 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.16e-05 | 185 | 121 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 1.19e-05 | 186 | 121 | 6 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | (5)_Glands_duct|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.19e-05 | 186 | 121 | 6 | ad8d5010e5095508f4995e0c6c016a44e8ffb8dd | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 187 | 121 | 6 | fe9fc21192ede2eea61f419d20ccda254569d0a6 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.27e-05 | 188 | 121 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-05 | 188 | 121 | 6 | 8ffb5394f7b00ea483a5fe4df894d22fda935e5c | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-05 | 188 | 121 | 6 | 137ed9958044fab7a13648affb469585d1c48cf6 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.31e-05 | 189 | 121 | 6 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-05 | 190 | 121 | 6 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.35e-05 | 190 | 121 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-05 | 190 | 121 | 6 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 1.43e-05 | 192 | 121 | 6 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 193 | 121 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 193 | 121 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 193 | 121 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-05 | 195 | 121 | 6 | 38ed4f48d450119cd50d6b85bd2d966a39d02c6b | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.56e-05 | 195 | 121 | 6 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-05 | 195 | 121 | 6 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.61e-05 | 196 | 121 | 6 | b246e482f012dd9782b49c2a953acedfa3c1139d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.61e-05 | 196 | 121 | 6 | 808c0a7d1889a8f3508ed9790c6dc7ec16bbc840 | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.61e-05 | 196 | 121 | 6 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.61e-05 | 196 | 121 | 6 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 1.65e-05 | 197 | 121 | 6 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-05 | 199 | 121 | 6 | bbb4798d6a24e756fea744a151ba67c1bafbac9a | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 155 | 121 | 5 | d0c1608f8f6b6f4174e51d610501c707cba5e015 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 6.76e-05 | 156 | 121 | 5 | 7e6805ebc7bc2f9c5965321d16922c155719970f | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.76e-05 | 156 | 121 | 5 | 55ba43cec9d79f309e9f633a6469cf03bb621e64 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.76e-05 | 156 | 121 | 5 | 60f1ce38e34b582f589db1e0d6139282c1902b2b | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.76e-05 | 156 | 121 | 5 | 44ff0acdd5cc3575d6c24a1c2ba11cd9f55359d1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like-IPs_and_early_cortical_neurons|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 6.76e-05 | 156 | 121 | 5 | 741de05295b2d012ac8576378f37709a97c8fb50 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.39e-05 | 159 | 121 | 5 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 159 | 121 | 5 | 656aa20706bdba81bbcc3e68e6058215b92b8802 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 160 | 121 | 5 | 237430af14830b38e58da8a4224036e5c6b71c5b | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.08e-05 | 162 | 121 | 5 | 59f6a9005c4f22f084c25ea36f3cacce5144a9ae | |
| ToppCell | CD8+_Memory_T_cell-FLU-1|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.08e-05 | 162 | 121 | 5 | 76f39935763848ea6e7917b2f9f1432c543063d9 | |
| ToppCell | Control-MAIT|World / Disease group and Cell class | 8.31e-05 | 163 | 121 | 5 | 0ca4b835936b4f82217cbe57210c1dd90986c1d0 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-05 | 163 | 121 | 5 | a0315855c354e830e109d41bd6e3396488aa8de9 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.81e-05 | 165 | 121 | 5 | 1c630f9ecde2e0243922a2be4b1ab5adcfcb0893 | |
| ToppCell | facs-Kidney-nan-24m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 165 | 121 | 5 | a359dda24c2c10b7b8df902a7c4c2ebf27b041f3 | |
| ToppCell | facs-Kidney-nan-24m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 165 | 121 | 5 | 1d5880aa49e6e6e95bde14a40fbe6e40b71c6d22 | |
| ToppCell | facs-Kidney-nan-24m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 165 | 121 | 5 | cdc09cbfd6eaeb8e436d83bbca7146bde3b3f01e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.81e-05 | 165 | 121 | 5 | 34fd00be2b28716c871ad9fb356de84a299a0c01 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.06e-05 | 166 | 121 | 5 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.06e-05 | 166 | 121 | 5 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-05 | 166 | 121 | 5 | 6a948aefd283a2572da37b59dbc142b6e686b024 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-05 | 166 | 121 | 5 | 8d0c4eb90a2c006f96ae61d3d94c96fb64bc0c4d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.06e-05 | 166 | 121 | 5 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.32e-05 | 167 | 121 | 5 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.32e-05 | 167 | 121 | 5 | fd84a99ea142d1684cdcf4a88ef1d541760bc78a | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-05 | 168 | 121 | 5 | d72cd8238fa793bb3e4add4c59eaaaadcea9930d | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.59e-05 | 168 | 121 | 5 | 2163e6774eb7a3d010422e4d59be5e45b4158329 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-05 | 168 | 121 | 5 | 2c996d09b6a8ccd3c708146eca310b02eafff425 | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-05 | 168 | 121 | 5 | c34c52165485f612add7a3e35a175d5a6e365e7c | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1|TCGA-Uvea / Sample_Type by Project: Shred V9 | 9.59e-05 | 168 | 121 | 5 | b427746929bb40e3d1b5f1c40d302b792d6b32a5 | |
| ToppCell | facs-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-05 | 168 | 121 | 5 | d2afc097ae1243574210be6a751685f949ea941a | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.86e-05 | 169 | 121 | 5 | 40b557549fe08c5dc9dba359af35993d68d1640a | |
| ToppCell | droplet-Fat-Gat-18m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 170 | 121 | 5 | 5185187ecf26b4c9eaa0c01ad52697ab8d075cc7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-04 | 170 | 121 | 5 | adb625124832b0786a590e8f75b61e7263a1e0d4 | |
| ToppCell | 15-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 1.01e-04 | 170 | 121 | 5 | 1418031cc4b4a87a48621eb53a3c819cd713ddd0 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.01e-04 | 170 | 121 | 5 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-04 | 170 | 121 | 5 | 6686d1797988216c0d9417f21a2537369abce410 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 171 | 121 | 5 | d1c5540e59c64eb233acab53bfd0d68e922a74bb | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-04 | 171 | 121 | 5 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 171 | 121 | 5 | 584a095ddcbf78aa29527f84b46b5ad3e2edbaa9 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 171 | 121 | 5 | 8bed33f61f7d12a1ac4fba33f730d839f5ee7bef | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-04 | 171 | 121 | 5 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 171 | 121 | 5 | 7c4362eeacbe52d7f4fdf93c841d7b59526328c1 | |
| ToppCell | Adult-Immune-B_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.04e-04 | 171 | 121 | 5 | 355a246f3395900342d400f6f7c6640cba0d4d5d | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-04 | 171 | 121 | 5 | 38a05b5ec8ef8f09a2399994c6b4b9a707918ec1 | |
| ToppCell | Immune_cells-B_cell|Immune_cells / Lineage and Cell class | 1.07e-04 | 172 | 121 | 5 | b646894b691a99bf2742bd9da8e578dff0e87f1f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 173 | 121 | 5 | c2d973356c40e0284fd3bd7733a164b141c66008 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 173 | 121 | 5 | 49030c2dd04b592655df1a667e2f90efb499e0a5 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 173 | 121 | 5 | 1cfbab6603f8baf8e238837bb72740c43a7dc0ec | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 173 | 121 | 5 | d8e965ff7e9b758876ec1521c1ccedd739e8d673 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-04 | 173 | 121 | 5 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | Immune_cells-pro-B|World / Lineage and Cell class | 1.13e-04 | 174 | 121 | 5 | e173adbf5789dfa20f3cbc668efde5f0992ac219 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 175 | 121 | 5 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 175 | 121 | 5 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | (1)_B_cell-(100)_CD19+_Naive_B_cell|(1)_B_cell / immune cells in Peripheral Blood (logTPM normalization) | 1.19e-04 | 176 | 121 | 5 | 08bf8485422fce1a4a3b1e7f6b9fab735ce61d46 | |
| ToppCell | (1)_B_cell-(10)_B_cell-(100)_CD19+_Naive_B_cell|(10)_B_cell / immune cells in Peripheral Blood (logTPM normalization) | 1.19e-04 | 176 | 121 | 5 | 184f46f01d30630e4bc14eaefb3de9e2a147ccd4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-04 | 176 | 121 | 5 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| Drug | Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 9.64e-06 | 196 | 120 | 8 | 7187_DN | |
| Drug | Propidium iodide [25535-16-4]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.00e-05 | 197 | 120 | 8 | 6277_DN | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 1.00e-05 | 197 | 120 | 8 | 5311_DN | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 1.08e-05 | 199 | 120 | 8 | 7250_UP | |
| Drug | Contact Lens Solutions | 2.75e-05 | 2 | 120 | 2 | ctd:D018639 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 3.75e-05 | 173 | 120 | 7 | 5612_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 3.89e-05 | 174 | 120 | 7 | 1302_UP | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 6.34e-05 | 188 | 120 | 7 | 5116_DN | |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; HL60; HG-U133A | 6.34e-05 | 188 | 120 | 7 | 1395_UP | |
| Drug | Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; PC3; HT_HG-U133A | 7.73e-05 | 194 | 120 | 7 | 6616_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 7394_DN | |
| Drug | Cefoperazone dihydrate; Up 200; 5.8uM; HL60; HG-U133A | 7.98e-05 | 195 | 120 | 7 | 1627_UP | |
| Drug | Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 7400_DN | |
| Drug | DAPM | 8.16e-05 | 135 | 120 | 6 | CID000007577 | |
| Drug | alpha-bromo-4-chlorophenylacetic acid | 8.24e-05 | 3 | 120 | 2 | CID010490868 | |
| Drug | Boric Acids | 8.24e-05 | 3 | 120 | 2 | ctd:D001888 | |
| Drug | l-945 | 8.24e-05 | 3 | 120 | 2 | CID000097919 | |
| Drug | Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 7228_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 2063_UP | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; PC3; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 7141_DN | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; HL60; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 1332_DN | |
| Drug | Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 6239_UP | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 7526_DN | |
| Drug | Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; HL60; HG-U133A | 8.78e-05 | 198 | 120 | 7 | 1426_DN | |
| Drug | Prednicarbate [73771-04-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 3542_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 3169_UP | |
| Drug | Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; PC3; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 5811_UP | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; HL60; HG-U133A | 9.06e-05 | 199 | 120 | 7 | 1403_UP | |
| Disease | Intellectual Disability | CACNA1B PCGF2 HIVEP2 BRSK2 BCL11A MED13L C12orf57 NRXN2 SETBP1 ZBTB40 MN1 MED13 | 1.90e-07 | 447 | 115 | 12 | C3714756 |
| Disease | Neurodevelopmental Disorders | 1.78e-06 | 93 | 115 | 6 | C1535926 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.90e-06 | 301 | 115 | 9 | DOID:684 (is_marker_for) | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 4.76e-06 | 9 | 115 | 3 | DOID:0050340 (implicated_via_orthology) | |
| Disease | cholangiocarcinoma (is_marker_for) | 5.23e-06 | 64 | 115 | 5 | DOID:4947 (is_marker_for) | |
| Disease | hematocrit | HIVEP1 HIVEP2 NUMBL RTEL1 BCORL1 FBRSL1 GLIS3 GATA5 BCL11A ZFPM1 STIM1 ARID2 TOX3 ZBTB40 MYRF | 9.31e-06 | 1011 | 115 | 15 | EFO_0004348 |
| Disease | Coffin-Siris syndrome | 1.60e-05 | 13 | 115 | 3 | C0265338 | |
| Disease | serine/threonine-protein kinase BRSK2 measurement | 4.51e-05 | 3 | 115 | 2 | EFO_0803063 | |
| Disease | pancreatic cancer (is_marker_for) | 4.84e-05 | 101 | 115 | 5 | DOID:1793 (is_marker_for) | |
| Disease | forced expiratory volume | RARB ZNF628 FAM182B GLIS3 PARD3B GATA5 MED15 WT1-AS SMARCA2 ZBTB40 MUC1 MN1 | 6.12e-05 | 789 | 115 | 12 | EFO_0004314 |
| Disease | Malignant neoplasm of breast | EVL RAP1GAP RARB BCORL1 BCL11A FOXA1 SHROOM2 SYNJ2 FARP1 SETBP1 TOX3 LRBA SPEN TP73 | 7.68e-05 | 1074 | 115 | 14 | C0006142 |
| Disease | Lung Neoplasms | 8.36e-05 | 265 | 115 | 7 | C0024121 | |
| Disease | Malignant neoplasm of lung | 8.56e-05 | 266 | 115 | 7 | C0242379 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.49e-04 | 5 | 115 | 2 | DOID:3030 (is_marker_for) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.49e-04 | 5 | 115 | 2 | C3281201 | |
| Disease | lung cancer (is_implicated_in) | 2.04e-04 | 74 | 115 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 2.24e-04 | 6 | 115 | 2 | EFO_0802705 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 2.24e-04 | 6 | 115 | 2 | EFO_0801767 | |
| Disease | mean reticulocyte volume | FOXJ2 RAP1GAP FBRSL1 BCL11A ZFPM1 STIM1 DIP2A ZNF469 ZBTB40 MN1 TMUB2 | 2.96e-04 | 799 | 115 | 11 | EFO_0010701 |
| Disease | breast cancer (is_implicated_in) | 3.11e-04 | 150 | 115 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | prostate cancer (is_marker_for) | 3.72e-04 | 156 | 115 | 5 | DOID:10283 (is_marker_for) | |
| Disease | common bile duct neoplasm (is_marker_for) | 4.15e-04 | 8 | 115 | 2 | DOID:4608 (is_marker_for) | |
| Disease | dry eye syndrome (is_marker_for) | 6.64e-04 | 10 | 115 | 2 | DOID:10140 (is_marker_for) | |
| Disease | cancer antigen 125 measurement | 6.64e-04 | 10 | 115 | 2 | EFO_0010603 | |
| Disease | allergic conjunctivitis (is_marker_for) | 6.64e-04 | 10 | 115 | 2 | DOID:11204 (is_marker_for) | |
| Disease | parental longevity | 7.22e-04 | 494 | 115 | 8 | EFO_0007796 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 7.32e-04 | 181 | 115 | 5 | DOID:684 (is_implicated_in) | |
| Disease | QRS-T angle | 8.01e-04 | 106 | 115 | 4 | EFO_0020097 | |
| Disease | Semantic-Pragmatic Disorder | 8.09e-04 | 11 | 115 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 8.09e-04 | 11 | 115 | 2 | C0751257 | |
| Disease | Language Delay | 8.09e-04 | 11 | 115 | 2 | C0023012 | |
| Disease | Language Development Disorders | 8.09e-04 | 11 | 115 | 2 | C0023014 | |
| Disease | Speech Delay | 8.09e-04 | 11 | 115 | 2 | C0241210 | |
| Disease | outer ear morphology trait | 9.69e-04 | 12 | 115 | 2 | EFO_0007664 | |
| Disease | lipoprotein A measurement | 9.84e-04 | 112 | 115 | 4 | EFO_0006925 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.02e-03 | 195 | 115 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | visceral:abdominal adipose tissue ratio measurement | 1.11e-03 | 52 | 115 | 3 | EFO_0803318 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 1.14e-03 | 13 | 115 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | Common variable immunodeficiency | 1.14e-03 | 13 | 115 | 2 | cv:C0009447 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.14e-03 | 13 | 115 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Sjogren's Syndrome | 1.14e-03 | 13 | 115 | 2 | C1527336 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 1.14e-03 | 13 | 115 | 2 | OBA_2045174 | |
| Disease | Sicca Syndrome | 1.14e-03 | 13 | 115 | 2 | C0086981 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.19e-03 | 118 | 115 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | Small cell carcinoma of lung | 1.24e-03 | 54 | 115 | 3 | C0149925 | |
| Disease | colorectal cancer (is_implicated_in) | 1.31e-03 | 121 | 115 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | ventricular septal defect (is_implicated_in) | 1.33e-03 | 14 | 115 | 2 | DOID:1657 (is_implicated_in) | |
| Disease | complement factor H measurement, protein binding measurement | 1.33e-03 | 14 | 115 | 2 | EFO_0008097, EFO_0010742 | |
| Disease | familial atrial fibrillation (is_implicated_in) | 1.33e-03 | 14 | 115 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | Libman-Sacks Disease | 1.52e-03 | 58 | 115 | 3 | C0242380 | |
| Disease | obesity (implicated_via_orthology) | 1.57e-03 | 215 | 115 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Tetralogy of Fallot | 1.74e-03 | 16 | 115 | 2 | C0039685 | |
| Disease | Abnormal behavior | 1.74e-03 | 16 | 115 | 2 | C0233514 | |
| Disease | Global developmental delay | 1.85e-03 | 133 | 115 | 4 | C0557874 | |
| Disease | otitis media (biomarker_via_orthology) | 1.97e-03 | 17 | 115 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | Profound Mental Retardation | 2.18e-03 | 139 | 115 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.18e-03 | 139 | 115 | 4 | C0025363 | |
| Disease | Mental deficiency | 2.18e-03 | 139 | 115 | 4 | C0917816 | |
| Disease | stomach cancer (is_marker_for) | 2.35e-03 | 142 | 115 | 4 | DOID:10534 (is_marker_for) | |
| Disease | Schizophrenia | SHANK1 CACNA1B NUMBL BCL11A ZDHHC8 MED15 ADM NRXN2 PIP4K2A SMARCA2 | 2.41e-03 | 883 | 115 | 10 | C0036341 |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 2.47e-03 | 19 | 115 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | colorectal cancer | 2.56e-03 | 604 | 115 | 8 | MONDO_0005575 | |
| Disease | diet measurement | TCAF1 RARB GLIS3 BCL11A ZNF469 ARID2 SMARCA2 TNFRSF13C SMARCA4 CHD6 SDK1 | 2.67e-03 | 1049 | 115 | 11 | EFO_0008111 |
| Disease | Lupus Erythematosus, Systemic | 2.72e-03 | 71 | 115 | 3 | C0024141 | |
| Disease | Alzheimer disease, educational attainment | 2.87e-03 | 247 | 115 | 5 | EFO_0011015, MONDO_0004975 | |
| Disease | Prostatic Neoplasms | 2.89e-03 | 616 | 115 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.89e-03 | 616 | 115 | 8 | C0376358 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.01e-03 | 152 | 115 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | stroke, coronary artery disease | 3.01e-03 | 21 | 115 | 2 | EFO_0000712, EFO_0001645 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 3.06e-03 | 74 | 115 | 3 | DOID:3748 (is_marker_for) | |
| Disease | serum gamma-glutamyl transferase measurement | 3.09e-03 | 914 | 115 | 10 | EFO_0004532 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 3.31e-03 | 22 | 115 | 2 | C1843687 | |
| Disease | colorectal cancer (is_marker_for) | 3.37e-03 | 157 | 115 | 4 | DOID:9256 (is_marker_for) | |
| Disease | free androgen index | 3.52e-03 | 374 | 115 | 6 | EFO_0007005 | |
| Disease | Autistic Disorder | 3.63e-03 | 261 | 115 | 5 | C0004352 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSAHPGSFLPTGPLT | 666 | Q9HCM7 | |
| QVPGTAHPSPATPSG | 126 | Q5SQH8 | |
| AAAAVPATSPPTPGH | 21 | A0A0U1RQF7 | |
| VPPPSGFTVHGLPTS | 266 | P33076 | |
| PAPGSASVPHSVPDA | 206 | Q5H9F3 | |
| SPAPSPAGIPHGSQT | 631 | Q68CP9 | |
| TLTGGPDGSPHPDPS | 466 | Q15517 | |
| PPPGHASAGPAAMSS | 46 | Q9NZU7 | |
| SSHPTSPTAGQEPGP | 2146 | Q00975 | |
| SHSGSGSKSSGPPPP | 6 | Q14444 | |
| SKPQAHGAPAPPSGS | 166 | P35318 | |
| TVAPGPAQPGHVSPT | 251 | Q9Y6R0 | |
| AGAPSGPAPHTPLAS | 261 | A6NCS4 | |
| GHPPPSGCSTPSPAT | 46 | P10826 | |
| TSPGGSSQPPHCPSV | 26 | O75106 | |
| GLDSPSHAAPGPSPD | 476 | O14526 | |
| PHSSPARGTPAGTTP | 211 | Q8IVT2 | |
| PTPPKTSHGEGVSPT | 11951 | Q8WXI7 | |
| APAPTGDGHTTQAPT | 696 | Q99102 | |
| THSPPTAGSPVPSTG | 1406 | Q6W4X9 | |
| HSPPTGSSPFSSTGP | 1576 | Q6W4X9 | |
| GPPADTQPSASHPGG | 146 | Q8TEW8 | |
| SSPPGASPPTGTNRH | 201 | Q9NQU5 | |
| ALGGEPSPPTHSPSR | 171 | A5PL33 | |
| PSTSHSGFPPVANGP | 566 | Q66K74 | |
| VPSPGSPSGIGVGSH | 2056 | Q71F56 | |
| IGTFPPPDHGSSGTP | 1126 | Q9HCH0 | |
| AGGSESHPVPPTAPL | 276 | Q7L2J0 | |
| ASGPSDGSPQPCTHP | 176 | O00221 | |
| LHASGPPGTANPPSA | 1461 | Q5JU85 | |
| PAPGSTAPPAHGVTS | 126 | P15941 | |
| PAPGSTAPPAHGVTS | 146 | P15941 | |
| PAPGSTAPPAHGVTS | 166 | P15941 | |
| PAPGSTAPPAHGVTS | 186 | P15941 | |
| PAPGSTAPPAHGVTS | 206 | P15941 | |
| PAPGSTAPPAHGVTS | 226 | P15941 | |
| PAPGSTAPPAHGVTS | 246 | P15941 | |
| PAPGSTAPPAHGVTS | 266 | P15941 | |
| PAPGSTAPPAHGVTS | 286 | P15941 | |
| PAPGSTAPPAHGVTS | 306 | P15941 | |
| PAPGSTAPPAHGVTS | 326 | P15941 | |
| PAPGSTAPPAHGVTS | 346 | P15941 | |
| PAPGSTAPPAHGVTS | 366 | P15941 | |
| PAPGSTAPPAHGVTS | 386 | P15941 | |
| PAPGSTAPPAHGVTS | 406 | P15941 | |
| PAPGSTAPPAHGVTS | 426 | P15941 | |
| PAPGSTAPPAHGVTS | 446 | P15941 | |
| PAPGSTAPPAHGVTS | 466 | P15941 | |
| PAPGSTAPPAHGVTS | 486 | P15941 | |
| PAPGSTAPPAHGVTS | 506 | P15941 | |
| PAPGSTAPPAHGVTS | 526 | P15941 | |
| PAPGSTAPPAHGVTS | 546 | P15941 | |
| PAPGSTAPPAHGVTS | 566 | P15941 | |
| PAPGSTAPPAHGVTS | 586 | P15941 | |
| PAPGSTAPPAHGVTS | 606 | P15941 | |
| PAPGSTAPPAHGVTS | 626 | P15941 | |
| PAPGSTAPPAHGVTS | 646 | P15941 | |
| PAPGSTAPPAHGVTS | 666 | P15941 | |
| PAPGSTAPPAHGVTS | 686 | P15941 | |
| PAPGSTAPPAHGVTS | 706 | P15941 | |
| PAPGSTAPPAHGVTS | 726 | P15941 | |
| PAPGSTAPPAHGVTS | 746 | P15941 | |
| PAPGSTAPPAHGVTS | 766 | P15941 | |
| PAPGSTAPPAHGVTS | 786 | P15941 | |
| PAPGSTAPPAHGVTS | 806 | P15941 | |
| PAPGSTAPPAHGVTS | 826 | P15941 | |
| PAPGSTAPPAHGVTS | 846 | P15941 | |
| PAPGSTAPPAHGVTS | 866 | P15941 | |
| PAPGSTAPPAHGVTS | 886 | P15941 | |
| PAPGSTAPPAHGVTS | 906 | P15941 | |
| PAPGSTAPPAHGVTS | 926 | P15941 | |
| GTPVHTPKESPAGTP | 446 | Q8IWQ3 | |
| STPHISGPGPGRPSS | 721 | Q9H165 | |
| APPEGATPTSPVGHF | 221 | P98177 | |
| GPILPPGHPSSAASA | 161 | Q9UI08 | |
| ATGPPSPLHPGADAT | 31 | Q5QP82 | |
| SHSQSGSGGIFPPPP | 606 | O15117 | |
| GHAPAPESPRPGSGS | 761 | Q8IX07 | |
| SGQPPPGTSGMAPHS | 126 | Q96RN5 | |
| PGVHTGSSRPPAPSS | 741 | Q9P1Y6 | |
| PAPSSHGSLAPLGPS | 751 | Q9P1Y6 | |
| KSGGASVVPHPSPTP | 96 | Q8NC54 | |
| VTPHTAPPGVSAGPD | 1621 | P50851 | |
| EPHEGPGSRSPTTSP | 416 | Q7L591 | |
| HSGGSSLPPTGPPST | 421 | Q6PI73 | |
| HSGGSSLPPTGPPST | 421 | O75022 | |
| TSPTGPAHGTRGPPS | 596 | Q96KJ4 | |
| GPSAVGGAPPLHTPS | 326 | Q9P0K8 | |
| SLPGPHPGGVSAPQS | 36 | Q5T319 | |
| TPSHGSPSSHGPPAT | 281 | P35227 | |
| SAPGFPHLPTANPTG | 556 | P58401 | |
| PHSSAATPNLGPVGP | 436 | O15350 | |
| SSGPGALASVPASHP | 361 | P55317 | |
| TSGSGPPPNSLAHPG | 946 | O14559 | |
| DSSAFGPGSPHPPAA | 71 | Q9BWX5 | |
| AGTAGHPPSGSQPLT | 451 | Q8TES7 | |
| TTHPEGPGPATSAPE | 2326 | Q8TD26 | |
| SGAPEPTPSHTGSPD | 131 | Q9P218 | |
| KVSAGEPGSHPSPAP | 416 | Q9Y4F1 | |
| SASAPPSRLSPPHGG | 711 | Q4ZHG4 | |
| SGTAAGAVPPPHPVS | 566 | Q8NEA6 | |
| PGSPRSSGGTPLHSP | 506 | Q8TDC3 | |
| PRTPSGSHSGPVPSQ | 466 | Q9Y6V7 | |
| GGSPTSHPLVTPGLS | 291 | Q12951 | |
| VVPATGPAPHSAGAG | 271 | Q6UY11 | |
| HPGGRPTTAPSAAAT | 186 | Q14689 | |
| VSGQAPSGTPTAPSH | 1001 | Q9NZM4 | |
| DVPGEPPGSVSATPH | 1576 | Q7Z5N4 | |
| GVGRSHKPTPAPSPA | 291 | Q9Y467 | |
| SASQPSLPHGAPGPA | 821 | Q9UL51 | |
| TLPPHGPAAGGSVAA | 111 | Q99622 | |
| GTHPVGTPPDSPGNT | 306 | P48426 | |
| TPHSGPGVNSPPSAG | 756 | Q10571 | |
| TALPFTTPAPGPAHG | 76 | Q5VT03 | |
| SQHGSPPAASAPPVA | 276 | Q96JB3 | |
| GPSQSSGPPHGPAAS | 1201 | Q9NZ71 | |
| GRPGSAHSPPDKPSS | 326 | A6NNA2 | |
| PDHSGGSPSPPTSEP | 46 | Q8TAD8 | |
| GSPSPPTSEPARSGH | 51 | Q8TAD8 | |
| HSSNPGPVPGSSSGP | 131 | Q99932 | |
| PEHVSSPMSGGGPTP | 131 | P51531 | |
| SPSGHPPAAGTVFPQ | 1366 | O15056 | |
| SSPGAPIGVHPSLAP | 86 | Q9Y4C2 | |
| SSSSPSPPLGTHNPG | 56 | P78426 | |
| SGGSSPGPSRSPHPD | 621 | P47736 | |
| PSPLGGSEHASSPVP | 121 | P51532 | |
| PHPSLGPTSETGFPS | 946 | Q9C0A6 | |
| PVFGEPSAPPHTSGV | 361 | Q6IA17 | |
| GLAQPPSSTSGGPHP | 731 | Q13796 | |
| EPFGPHSTLSASGPP | 211 | Q6ZUB1 | |
| SPHSSPGNTVSPVGP | 351 | O75626 | |
| VRTPGPPSGSHPAAA | 76 | Q06250 | |
| PASPTGSPVHSPGSH | 2016 | Q9UHV7 | |
| PSAPPGGSPHLDSSR | 601 | Q13586 | |
| TVAANIHPSGSGPTP | 1036 | Q92922 | |
| SPTPGAPSPSHHGSA | 1056 | Q9Y566 | |
| APAGSHAAPAQPGPT | 46 | P09497 | |
| GPSASSHGSPVPLPS | 76 | O15417 | |
| APPHCPGGSASPSSS | 856 | Q8IXZ2 | |
| GTTPSPGHNAPSLPS | 11 | Q9C0A1 | |
| LDAHSPRPSGPGPSS | 3021 | Q96T58 | |
| EESTGGPHSAPPTAP | 451 | P21580 | |
| GPPGAHRSPATSAGP | 421 | A1L020 | |
| PTPSHTPAGAATPGR | 256 | O75533 | |
| GAGPAASPHLSPSPA | 1206 | Q96MS0 | |
| HTPAGPPGPSSNPVS | 186 | Q9BQ15 | |
| SSGPEHPGPESSLPS | 376 | Q9H8N7 | |
| HRSPPGSAVPGPSAS | 241 | Q71RG4 | |
| GGASMPHTSPSPPAS | 191 | O15405 | |
| PSLAIPHPSVGGSPA | 401 | Q5SNT2 | |
| PPSRHDTGTPKPSGS | 1241 | Q96JG9 | |
| PPTSPLSGGSAPGAH | 166 | Q9P0L1 | |
| GFGSPEPSLPGTPHS | 126 | Q8N1G0 | |
| GPPGPSASPTRHTLV | 736 | Q9ULC8 | |
| PSGPGPEVHASTPGA | 366 | O60806 | |
| SLHPAAGPGTAFPSP | 41 | Q9H489 | |
| GPHALQSSGPPSTPS | 2286 | P31629 | |
| LGGVAPSPSSHSSPA | 286 | Q9Y6X0 | |
| PPGHSVPVPATELGS | 156 | Q96RJ3 | |
| PPSSPSRVGVTGHVP | 1406 | P15822 | |
| SQTKPGGSSPPAHPS | 206 | Q14202 | |
| EPHSSPELAATPGGP | 156 | Q9NUA8 | |
| HGAAPAPGTASAAPP | 226 | Q5EBL2 | |
| PAPAPASSAPGHVAK | 781 | Q9P206 | |
| GLATPPHKGAPTTPA | 1116 | E9PAV3 | |
| GPSFNPGHVLSPSPS | 901 | Q9Y2G1 |